Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Smit AK, Espinoza D, Newson AJ, Morton RL, Fenton G, Freeman L, Dunlop K, Butow PN, Law MH, Kimlin MG, Keogh LA, Dobbinson SJ, Kirk J, Kanetsky PA, Mann GJ, Cust AE. Smit AK, et al. Among authors: espinoza d. Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):212-221. doi: 10.1158/1055-9965.EPI-16-0395. Epub 2016 Oct 4. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 27702805 Clinical Trial.
Prevalence of skin examination behaviours among Australians over time.
Reyes-Marcelino G, Tabbakh T, Espinoza D, Sinclair C, Kang YJ, McLoughlin K, Caruana M, Fernández-Peñas P, Guitera P, Aitken JF, Canfell K, Dobbinson S, Cust AE. Reyes-Marcelino G, et al. Among authors: espinoza d. Cancer Epidemiol. 2021 Feb;70:101874. doi: 10.1016/j.canep.2020.101874. Epub 2020 Dec 17. Cancer Epidemiol. 2021. PMID: 33341599
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial.
Nair-Shalliker V, Smith DP, Gebski V, Patel MI, Frydenberg M, Yaxley JW, Gardiner R, Espinoza D, Kimlin MG, Fenech M, Gillatt D, Woo H, Armstrong BK, Rasiah K, Awad N, Symons J, Gurney H. Nair-Shalliker V, et al. Among authors: espinoza d. BMJ Open. 2021 Mar 2;11(3):e044055. doi: 10.1136/bmjopen-2020-044055. BMJ Open. 2021. PMID: 33653757 Free PMC article.
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
Ackermann DM, Smit AK, Janda M, van Kemenade CH, Dieng M, Morton RL, Turner RM, Cust AE, Irwig L, Hersch JK, Guitera P, Soyer HP, Mar V, Saw RPM, Low D, Low C, Drabarek D, Espinoza D, Emery J, Murchie P, Thompson JF, Scolyer RA, Azzi A, Lilleyman A, Bell KJL. Ackermann DM, et al. Among authors: espinoza d. Trials. 2021 May 4;22(1):324. doi: 10.1186/s13063-021-05231-7. Trials. 2021. PMID: 33947444 Free PMC article.
Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial.
Smit AK, Allen M, Beswick B, Butow P, Dawkins H, Dobbinson SJ, Dunlop KL, Espinoza D, Fenton G, Kanetsky PA, Keogh L, Kimlin MG, Kirk J, Law MH, Lo S, Low C, Mann GJ, Reyes-Marcelino G, Morton RL, Newson AJ, Savard J, Trevena L, Wordsworth S, Cust AE. Smit AK, et al. Among authors: espinoza d. Genet Med. 2021 Dec;23(12):2394-2403. doi: 10.1038/s41436-021-01292-w. Epub 2021 Aug 12. Genet Med. 2021. PMID: 34385669 Free PMC article. Clinical Trial.
185 results